Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 66,613,246 $ 85,433,441
Marketable securities 57,399,179
Restricted cash 350,000 350,000
Stock subscriptions receivable 960,033
Prepaid expenses and other current assets 3,658,794 3,712,861
Contract asset 2,266,120 1,618,296
Total current assets 130,287,339 92,074,631
Restricted cash 669,900 669,900
Property and equipment, net 3,787,596 4,067,837
Operating lease right of use assets 5,096,165 5,248,525
Other assets 304,037 234,038
Total assets 140,145,037 102,294,931
Current liabilities:    
Notes payable 408,278 710,158
Accounts payable 3,615,366 7,381,183
Accrued expenses 17,742,474 22,005,432
Derivative liability 803,000 797,000
Operating lease liabilities, current 1,036,297 1,004,063
Total current liabilities 23,605,415 31,897,836
Long-term debt, net of debt discount 18,199,289 18,029,005
Operating lease liabilities, noncurrent 6,823,339 7,093,165
Total liabilities 48,628,043 57,020,006
Stockholders’ equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2021 and December 31, 2020
Common stock, $0.0001 par value; 150,000,000 shares authorized, 125,033,006 and 98,852,696 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 12,503 9,885
Additional paid-in capital 411,691,762 349,358,378
Accumulated deficit (320,158,506) (304,093,338)
Accumulated other comprehensive loss (28,765)
Total stockholders’ equity 91,516,994 45,274,925
Total liabilities and stockholders’ equity $ 140,145,037 $ 102,294,931